Headline
The latest stories from AHA Today.
The Food and Drug Administration further expanded the authorized use of remdesivir for treating COVID-19 patients, the agency announced. Now, remdesivir can be used for all admitted COVID-19 patients, confirmed or suspected, whether on oxygen, off oxygen or intubated.
Two new case studies highlight how hospitals and health systems are customizing care for older adult patients.
A Centers for Disease Control and Prevention study released shows an increase between 2018 and 2019 in rates of suspected nonfatal drug overdoses involving opioids, cocaine and amphetamines, and of polydrug overdoses co-involving opioids and amphetamines that were treated in the emergency…
State Opioid Response and Tribal Opioid Response grant programs are receiving the first of two rounds of funds totaling $1.5 billion, the Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration announced.
Clinicians who may see patients from areas affected by Hurricane Laura should maintain a high level of suspicion for carbon monoxide poisoning, the Centers for Disease Control and Prevention said in new guidance.
The federal appeals court in Washington, D.C., should overturn a lower court ruling upholding a Department of Health and Human Services final rule requiring hospitals to disclose the rates they agree to accept from insurers, the AHA told the court , joined by the Association of American Medical…
Those with intellectual and developmental disabilities who require in-person care, including in-classroom settings, are disproportionately affected by the COVID-19 pandemic, the directors of the National Institutes of Health-funded Intellectual and Developmental Disabilities Research Centers…
The Centers for Disease Control and Prevention credited universal testing of residents and staff of all 123 West Virginia nursing homes for SARS-CoV-2, irrespective of symptoms, as a key factor for limiting COVID-19 transmissions and reducing the pandemic’s impact on the state’s vulnerable…
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases announced $17 million in grants to establish the Centers for Research in Emerging Infectious Diseases, which will support multidisciplinary investigations into how and where viruses and other pathogens emerge…
If you missed the Aug. 27 livestream, you can watch a replay of the latest episode of Leadership Rounds – short conversations on a range of key issues AHA Board Chair Melinda Estes, M.D., is having with hospital and health system leaders from across the country.